NCT00791050

Brief Summary

Although data on cardioprotective effects (as profile of troponin I)of perioperative maintenance of normothermia during CABGs are already known, little is known about the effects of maintaining normothermia on clinical outcomes of patients submitted to coronary surgery. Being acute renal failure (ARF) and atrial fibrillation (AF) the two most frequent complications of this surgery, this study compare as primary end point the rate of postoperative ARF and AF in two group of patients, one actively warmed with Thermowrap and the control group receiving standard institutional care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2009

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 13, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 14, 2008

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2010

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

November 14, 2008

Status Verified

October 1, 2008

Enrollment Period

1 year

First QC Date

November 13, 2008

Last Update Submit

November 13, 2008

Conditions

Keywords

Hypothermia/complications/etiologycoronary artery bypass/adverse effects

Outcome Measures

Primary Outcomes (2)

  • Rate of atrial fibrillation

    First 48 postoperative hours

  • Rate of acute renal failure

    First 48 postoperative hours

Secondary Outcomes (8)

  • Rate of Myocardial infarction and low output syndrome

    First postoperative 48 hours

  • Rate of Type I neurological injury

    First 48 postoperative hours

  • Total units of RBCs transfused

    First 48 postoperative hours

  • Length of mechanical ventilation

    First 48 postoperative hours

  • Rate of in-hospital mortality

    30 postoperative days

  • +3 more secondary outcomes

Study Arms (2)

1 Thermo

EXPERIMENTAL
Device: Allon Thermowrap. MTRE Advanced Technologies Ltd.

2 Control

NO INTERVENTION

Interventions

Thermowrap set at 37 °C before induction of anesthesia and maintained until initiation of CPB; during CPB set to "monitoring" and set again to 37 °C from rewarming during CPB to end of surgery.

1 Thermo

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Isolated on pump CABGs
  • Age 18 - 85
  • Preoperative core temperature 36- 37.5 °C

You may not qualify if:

  • History of fever in the last week
  • Severe renal, hepatic,hematologic or pulmonary disease
  • Chronic Atrial fibrillation
  • History of acute MI in the last week
  • Previous neurologic abnormalities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of Anesthesia & ICU, IRCCS Centro Cardiologico Monzino

Milan, Italy

Location

Related Publications (1)

  • Nesher N, Zisman E, Wolf T, Sharony R, Bolotin G, David M, Uretzky G, Pizov R. Strict thermoregulation attenuates myocardial injury during coronary artery bypass graft surgery as reflected by reduced levels of cardiac-specific troponin I. Anesth Analg. 2003 Feb;96(2):328-35, table of contents. doi: 10.1097/00000539-200302000-00007.

    PMID: 12538173BACKGROUND

MeSH Terms

Conditions

Hypothermia

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Luca Salvi, MD

    Dept. of Anesthesia & ICU, IRCCS Centro Cardiologico Monzino. Milano, Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 13, 2008

First Posted

November 14, 2008

Study Start

January 1, 2009

Primary Completion

January 1, 2010

Study Completion

March 1, 2010

Last Updated

November 14, 2008

Record last verified: 2008-10

Locations